NDC 0002-7752-01 - Insulin Lispro
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0002-7752
- Requested NDC
- 0002-7752-01
- Package NDCs from labels
- 0002-7752-01, 0002-7752-05
- Manufacturer
- Eli Lilly and Company
- Effective date
- 2025-06-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Insulin Lispro - Eli Lilly and Company | Eli Lilly and Company | 2025-06-17 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0002-7752-05 | 2024-01-30 | C162847 | 48780-1 | 1030e365-2939-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use INSULIN LISPRO safely and effectively. See full prescribing information for INSULIN LISPRO. INSULIN LISPRO injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996 This product is HUMALOG ® (insulin lispro). |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0002-7752-01 | Insulin Lispro Junior KwikPen | 3 mL in 1 SYRINGE | INJECTION, SOLUTION | 3 | 12 | |
| 0002-7752-05 | Insulin Lispro Junior KwikPen | 5 in 1 CARTON | INJECTION, SOLUTION | 5 | 12 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0002-7752 | INSULIN LISPRO INJECTION, SOLUTION INSULIN LISPRO KWIKPEN (INSULIN LISPRO) INJECTION, SOLUTION INSULIN LISPRO JUNIOR KWIKPEN (INSULIN LISPRO) INJECTION, SOLUTION [ELI LILLY AND COMPANY] | 11 | Current NDC, Legacy NDC, 2 package rows | 20241213_97d5e596-aae1-42c9-ae89-c3780959c467.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0002-7752-01 | ML - Milliliter | 0002-7752 | a33dea4a-34d3-4aad-aee0-7ec8c9287ae0 | 1 | 2020-04-20 |
| 0002-7752-05 | ML - Milliliter | 0002-7752 | 4b567318-1ca3-4059-a4dc-299cfcce16c3 | 1 | 2020-04-20 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Equaline Redness Relief Lubricant Eye Drops | GLYCERIN, NAPHAZOLINE HYDROCHLORIDE | United Natural Foods, Inc | 31a30b00-9f4b-717a-e063-6394a90a8a87 | 2024-01-01 | Warnings | PDC6A3C0OX |
| Harris Teeter Redness Relief Eye Drops | GLYCERIN, NAPHAZOLINE HYDROCHLORIDE | Harris Teeter, LLC. | 31a3d575-10f1-5feb-e063-6294a90ac478 | 2024-01-01 | Warnings | PDC6A3C0OX |
| Discount Drug Mart Redness Relief Eye Drops | GLYCERIN, NAPHAZOLINE HYDROCHLORIDE | Discount Drug Mart, Inc. | 31a98e6c-42df-6b56-e063-6294a90a3564 | 2024-01-01 | Warnings | PDC6A3C0OX |
| Calamine Phenolated Topical Suspension | CALAMINE AND ZINC OXIDE AND PHENOL | Pharma Nobis, LLC | e42fbdcc-3291-7761-e053-2995a90a7172 | 2023-12-26 | Warnings | 339NCG44TV |
| Equate Eye Drops Dry Eye Relief | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | Wal-Mart Stores, Inc. | 91fb8fb5-b871-4535-e053-2995a90a9b16 | 2023-12-23 | Warnings | PDC6A3C0OX |
| Sunmark Dry Eye Relief | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | Strategic Sourcing Services LLC | 043ccc34-44ee-416a-88bc-f247774e9075 | 2023-12-23 | Warnings | PDC6A3C0OX |
| Leader Eye Wash | PURIFIED WATER | Cardinal Health | 8d3ad11f-1945-f838-e053-2995a90a7aa5 | 2023-12-23 | Warnings | 059QF0KO0R |
| Rite Aid Eye Drops Dry Eye Relief | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | Rite Aid Corporation | fa1b5b66-9643-e9a7-e053-6394a90ae3cf | 2023-12-23 | Warnings | PDC6A3C0OX |
| Antiseptic Instant Pain Relief | CAMPHOR 10.8% AND PHENOL 4.7% | Pharma Nobis, LLC | e42f484d-a642-3489-e053-2a95a90a4254 | 2023-12-22 | Warnings | 339NCG44TV |
| Meijer Maximum Redness Relief and Lubricant | GLYCERIN, NAPHAZOLINE HCI | Meijer Distribution, Inc. | 9feb1818-c79b-23bf-e053-2995a90a1084 | 2023-12-22 | Warnings | PDC6A3C0OX |
| Meijer Redness Relief | GLYCERIN, NAPHAZOLINE HCI | Meijer Distribution, Inc. | 9fea4e43-7525-bb66-e053-2a95a90acee9 | 2023-12-22 | Warnings | PDC6A3C0OX |
| Meijer Dry Eye Relief | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | Meijer Distribution, Inc. | 9feaa5e2-6aca-96e8-e053-2a95a90a54bd | 2023-12-22 | Warnings | PDC6A3C0OX |
| Instant Antiseptic Pain Relief | CAMPHOR 10.8% AND PHENOL 4.7% | Chain Drug Market Association | 2cd60df3-bfde-4747-ba4f-7121612f2e63 | 2023-12-20 | Warnings | 339NCG44TV |
| Premier Value Instant Antiseptic Pain Relief | CAMPHOR 10.8% AND PHENOL 4.7% | Pharmacy Value Alliance LLC | 9d63f8ed-fc50-0d84-e053-2a95a90a6e92 | 2023-12-20 | Warnings | 339NCG44TV |
| Walgreens Multi-Symptom Relief Eye Drops | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400, TETRAHYDROZOLINE HCL, ZINC SULFATE | Walgreen Co. | a03789ce-66bd-7b12-e053-2995a90af85a | 2023-12-20 | Warnings | PDC6A3C0OX |
| Walgreens Eye Drops Maximum Redness Relief 15mL | GLYCERIN, NAPHAZOLINE HCI | Walgreen Company | 949d4a4d-b0f8-81f8-e053-2995a90a818d | 2023-12-20 | Warnings | PDC6A3C0OX |
| Walgreens Redness Relief Eye Drops 15mL | GLYCERIN, NAPHAZOLINE HCI | Walgreen Company | 94a0d08a-a6db-1088-e053-2995a90ab4fd | 2023-12-20 | Warnings | PDC6A3C0OX |
| Target Eye Drops Maximum Redness Relief Eye | GLYCERIN, NAPHAZOLINE HYDROCHLORIDE | Target Corporation | 1b26cd3b-4a05-4623-b320-01f22b3106ff | 2023-12-20 | Warnings | PDC6A3C0OX |
| TopCare Health Dry Eye Relief Eye Drops | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | Topco Associates LLC | 9c617e34-fc66-1a5b-e053-2995a90ace2c | 2023-12-20 | Warnings | PDC6A3C0OX |
| HEB Dry Eye Eye Drops | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | HEB | f80023cf-8e42-780a-e053-6294a90a66cd | 2023-12-20 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.